As of 2025-07-09, the EV/EBITDA ratio of Qingdao Vland Biotech INC (603739.SS) is 27.24. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 603739.SS's latest enterprise value is 3,844.84 mil CNY. 603739.SS's TTM EBITDA according to its financial statements is 141.13 mil CNY. Dividing these 2 quantities gives us the above 603739.SS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 24.6x - 28.5x | 27.2x |
| Forward P/E multiples | 9.7x - 16.9x | 11.1x |
| Fair Price | 11.99 - 30.93 | 16.59 |
| Upside | -10.8% - 130.1% | 23.4% |
| Date | EV/EBITDA |
| 2025-05-29 | 27.89 |
| 2025-05-28 | 28.12 |
| 2025-05-27 | 28.02 |
| 2025-05-26 | 27.15 |
| 2025-05-23 | 26.81 |
| 2025-05-22 | 27.01 |
| 2025-05-21 | 27.78 |
| 2025-05-20 | 28.23 |
| 2025-05-19 | 27.53 |
| 2025-05-16 | 27.96 |
| 2025-05-15 | 27.73 |
| 2025-05-14 | 26.69 |
| 2025-05-13 | 26.35 |
| 2025-05-12 | 26.40 |
| 2025-05-09 | 26.35 |
| 2025-05-08 | 26.53 |
| 2025-05-07 | 26.37 |
| 2025-05-06 | 26.28 |
| 2025-04-30 | 25.52 |
| 2025-04-29 | 25.68 |
| 2025-04-28 | 25.45 |
| 2025-04-25 | 25.58 |
| 2025-04-24 | 25.68 |
| 2025-04-23 | 26.49 |
| 2025-04-22 | 26.74 |
| 2025-04-21 | 27.05 |
| 2025-04-18 | 26.78 |
| 2025-04-17 | 28.48 |
| 2025-04-16 | 28.86 |
| 2025-04-15 | 30.33 |
| 2025-04-14 | 28.93 |
| 2025-04-11 | 28.27 |
| 2025-04-10 | 29.83 |
| 2025-04-09 | 29.57 |
| 2025-04-08 | 32.50 |
| 2025-04-07 | 32.21 |
| 2025-04-03 | 30.33 |
| 2025-04-02 | 27.85 |
| 2025-04-01 | 28.18 |
| 2025-03-31 | 25.90 |
| 2025-03-28 | 27.41 |
| 2025-03-27 | 27.60 |
| 2025-03-26 | 27.19 |
| 2025-03-25 | 26.26 |
| 2025-03-24 | 26.33 |
| 2025-03-21 | 26.38 |
| 2025-03-20 | 26.96 |
| 2025-03-19 | 27.12 |
| 2025-03-18 | 27.37 |
| 2025-03-17 | 27.41 |